Until Labs Secures $58 Million Series A Funding Round Led By Founders Fund

Until Labs announced a $58 million Series A funding round, led by Founders Fund with participation from Lux Capital and Field Ventures, bringing its total funding to more than $100 million. Co-founded by Laura Deming and Hunter Davis, the San Francisco-based company is developing perfusion hardware, cryoprotective agents, and rewarming infrastructure to enable reversible cryopreservation of organs for transplant. The new capital will support team growth across multiple scientific disciplines and the buildout of operational infrastructure, advancing Until’s mission to pause biological time—starting with organs and ultimately aiming toward whole-body medical hibernation technology. INVESTORS: Founders Fund, Lux Capital & Field Ventures ROUND: Series A AMOUNT: $58,000,000 HQ: #SanFrancisco #California #VentureCapital #UntilLabs #LauraDeming #HunterDavis #FoundersFund #LuxCapital #FieldVentures #TradedVC